Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

iFabric Corp T.IFA

Alternate Symbol(s):  IFABF

iFabric Corp. is a Canada-based company, which is engaged in the business of designing and distributing women's intimate apparel. The Company is also in the business of developing and distributing a range of products and treatments that are suitable for application to textiles, plastics, liquids, hard surfaces and finished performance apparel which integrate one or more such treatments. Its two divisions offer a variety of products and services through wholly owned subsidiaries, namely Intelligent Fabric Technologies (North America) Inc. (IFTNA) and Coconut Grove Pads Inc. (Coconut Grove). IFTNA is focused on development and sale of sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide properties to fabrics, foams, plastics, and numerous other surfaces. Coconut Grove operates as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies’ intimate apparel products and accessories.


TSX:IFA - Post by User

Bullboard Posts
Comment by smoke1legalon Apr 06, 2020 11:12am
102 Views
Post# 30882861

RE:$4.50 analyst target

RE:$4.50 analyst targetThat $4.50 target may be revised in three weeks once they get the independent test confirming COVIS19.  
Bullboard Posts